|

CETEG Clinical Trials

1 actively recruiting trial

Also known as: Lomustine (CCNU) and Temozolomide

Pipeline

Phase 3: 1

Top Sponsors

  • University Hospital Heidelberg1

Indications

  • Oligodendroglioma1
  • Cancer1

Other1 trial

A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.